• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

E1A 通过其 p300/CBP 相互作用区域对 p53 介导的反式激活和细胞周期停滞的抑制作用。

Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region.

作者信息

Somasundaram K, El-Deiry W S

机构信息

Department of Medicine and Genetics, University of Pennsylvania School of Medicine and Comprehensive Cancer Center, Philadelphia 19104, USA.

出版信息

Oncogene. 1997 Mar 6;14(9):1047-57. doi: 10.1038/sj.onc.1201002.

DOI:10.1038/sj.onc.1201002
PMID:9070653
Abstract

Cellular transformation by the adenovirus E1A oncoprotein requires its p300/CBP- and Rb-binding domains. We mapped inhibition of p53-mediated transactivation to the p300/CBP-binding region of E1A. An E1A mutant incapable of physically interacting with Rb retained the capacity to inhibit transactivation by p53, whereas E1A mutants of the p300/CBP-interacting domain failed to inhibit p53. The inhibitory effect of the p300/CBP-binding region of E1A on p53 was demonstrated with p53-activated reporters and endogenous p53 targets such as p21(WAF1/CIP1) or MDM2. E1A lacking the capacity to interact with Rb, but capable of p300/CBP interaction, was competent in suppression of a DNA-damage activated p53-dependent cell cycle checkpoint. Exogenous CBP and p300 were able to individually relieve E1A's inhibitory effect on p53-mediated transcription. Mutants of E1A that are not capable of interacting with p300 or CBP were found to efficiently stabilize endogenous p53 but were not competent in repression of p21 expression thus dissociating these two effects of E1A. Our results suggest that the p300/CBP-binding domain of E1A inhibits a p53-dependent cellular response which normally inhibits DNA replication following Adenovirus infection.

摘要

腺病毒E1A癌蛋白介导的细胞转化需要其p300/CBP结合域和Rb结合域。我们将p53介导的反式激活抑制定位到E1A的p300/CBP结合区域。一个不能与Rb发生物理相互作用的E1A突变体保留了抑制p53反式激活的能力,而p300/CBP相互作用域的E1A突变体则无法抑制p53。用p53激活的报告基因以及内源性p53靶标如p21(WAF1/CIP1)或MDM2证实了E1A的p300/CBP结合区域对p53的抑制作用。缺乏与Rb相互作用能力但能够与p300/CBP相互作用的E1A能够抑制DNA损伤激活的p53依赖性细胞周期检查点。外源性CBP和p300能够分别解除E1A对p53介导转录的抑制作用。发现不能与p300或CBP相互作用的E1A突变体能够有效地稳定内源性p53,但不能抑制p21的表达,从而使E1A的这两种作用分离。我们的结果表明,E1A的p300/CBP结合域抑制了p53依赖性细胞反应,这种反应通常在腺病毒感染后抑制DNA复制。

相似文献

1
Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region.E1A 通过其 p300/CBP 相互作用区域对 p53 介导的反式激活和细胞周期停滞的抑制作用。
Oncogene. 1997 Mar 6;14(9):1047-57. doi: 10.1038/sj.onc.1201002.
2
The ability of E1A to rescue ras-induced premature senescence and confer transformation relies on inactivation of both p300/CBP and Rb family proteins.E1A挽救ras诱导的早衰并赋予细胞转化能力,这依赖于p300/CBP和Rb家族蛋白的失活。
Cancer Res. 2005 Sep 15;65(18):8298-307. doi: 10.1158/0008-5472.CAN-05-0054.
3
Functional interplay between p53 and E2F through co-activator p300.通过共激活因子p300实现p53与E2F之间的功能相互作用。
Oncogene. 1998 May 28;16(21):2695-710. doi: 10.1038/sj.onc.1201818.
4
E1A physically interacts with RUNX3 and inhibits its transactivation activity.E1A与RUNX3发生物理相互作用并抑制其反式激活活性。
J Cell Biochem. 2008 Sep 1;105(1):236-44. doi: 10.1002/jcb.21818.
5
A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A.一种与腺病毒癌蛋白E1A竞争的p300/CBP相关因子。
Nature. 1996 Jul 25;382(6589):319-24. doi: 10.1038/382319a0.
6
Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.Myc对p21(Cip1)细胞周期蛋白依赖性激酶抑制剂的抑制作用影响p53对DNA损伤反应的结果。
Nature. 2002 Oct 17;419(6908):729-34. doi: 10.1038/nature01119. Epub 2002 Oct 2.
7
Roles of p300, pocket proteins, and hTBP in E1A-mediated transcriptional regulation and inhibition of p53 transactivation activity.p300、口袋蛋白和人TATA结合蛋白在E1A介导的转录调控及p53反式激活活性抑制中的作用。
J Cell Biochem. 1997 Sep 1;66(3):277-85. doi: 10.1002/(sici)1097-4644(19970901)66:3<277::aid-jcb1>3.0.co;2-m.
8
Lack of correlation between p53 protein level and sensitivity of DNA-damaging agents in keratinocytes carrying adenovirus E1a mutants.携带腺病毒E1a突变体的角质形成细胞中p53蛋白水平与DNA损伤剂敏感性之间缺乏相关性。
Oncogene. 1995 Aug 17;11(4):675-82.
9
HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.HIPK2在非凋亡性DNA损伤后有助于PCAF介导的p53乙酰化及p21Waf1的选择性反式激活。
Oncogene. 2005 Aug 18;24(35):5431-42. doi: 10.1038/sj.onc.1208717.
10
Transcriptional regulation of the human glycoprotein hormone common alpha subunit gene by cAMP-response-element-binding protein (CREB)-binding protein (CBP)/p300 and p53.环磷酸腺苷反应元件结合蛋白(CREB)结合蛋白(CBP)/p300和p53对人糖蛋白激素共同α亚基基因的转录调控
Biochem J. 2002 Nov 15;368(Pt 1):191-201. doi: 10.1042/BJ20020634.

引用本文的文献

1
EZH2 promotes endometriosis progression through estrogen receptor and TNFα expression.EZH2通过雌激素受体和TNFα表达促进子宫内膜异位症进展。
Front Endocrinol (Lausanne). 2025 Jun 24;16:1574938. doi: 10.3389/fendo.2025.1574938. eCollection 2025.
2
AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer.AR 共激活因子,如 CBP/p300,是前列腺癌中 DNA 修复的关键介质。
Oncogene. 2024 Oct;43(43):3197-3213. doi: 10.1038/s41388-024-03148-4. Epub 2024 Sep 13.
3
AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer.
雄激素受体共激活因子CBP/p300是前列腺癌DNA修复的关键介质。
bioRxiv. 2024 May 7:2024.05.07.592966. doi: 10.1101/2024.05.07.592966.
4
Senescence-related gene c-Myc affects bladder cancer cell senescence by interacting with HSP90B1 to regulate cisplatin sensitivity.衰老相关基因 c-Myc 通过与 HSP90B1 相互作用影响膀胱癌细胞衰老,从而调节顺铂敏感性。
Aging (Albany NY). 2023 Jul 10;15(15):7408-7423. doi: 10.18632/aging.204863.
5
CBP/p300: Critical Co-Activators for Nuclear Steroid Hormone Receptors and Emerging Therapeutic Targets in Prostate and Breast Cancers.CBP/p300:核甾体激素受体的关键共激活因子以及前列腺癌和乳腺癌中新兴的治疗靶点
Cancers (Basel). 2021 Jun 8;13(12):2872. doi: 10.3390/cancers13122872.
6
miR-509-5p Inhibits the Proliferation and Invasion of Osteosarcoma by Targeting TRIB2.miR-509-5p 通过靶向 TRIB2 抑制骨肉瘤的增殖和侵袭。
Biomed Res Int. 2019 Dec 16;2019:2523032. doi: 10.1155/2019/2523032. eCollection 2019.
7
Aspirin Inhibits Natural Killer/T-Cell Lymphoma by Modulation of VEGF Expression and Mitochondrial Function.阿司匹林通过调节血管内皮生长因子(VEGF)表达和线粒体功能抑制自然杀伤/T细胞淋巴瘤。
Front Oncol. 2019 Jan 14;8:679. doi: 10.3389/fonc.2018.00679. eCollection 2018.
8
Transcriptomic and proteomic analyses reveal new insights into the regulation of immune pathways during adenovirus type 2 infection.转录组学和蛋白质组学分析揭示了腺病毒 2 型感染过程中免疫途径调控的新见解。
BMC Microbiol. 2019 Jan 14;19(1):15. doi: 10.1186/s12866-018-1375-5.
9
TRIB2 functions as novel oncogene in colorectal cancer by blocking cellular senescence through AP4/p21 signaling.TRIB2 通过阻断细胞衰老通过 AP4/p21 信号通路在结直肠癌中发挥 novel 癌基因的作用。
Mol Cancer. 2018 Dec 12;17(1):172. doi: 10.1186/s12943-018-0922-x.
10
Breaking Bad: How Viruses Subvert the Cell Cycle.《绝命毒师:病毒如何颠覆细胞周期》。
Front Cell Infect Microbiol. 2018 Nov 19;8:396. doi: 10.3389/fcimb.2018.00396. eCollection 2018.